250 related articles for article (PubMed ID: 9529328)
1. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity.
Giuliani MM; Del Giudice G; Giannelli V; Dougan G; Douce G; Rappuoli R; Pizza M
J Exp Med; 1998 Apr; 187(7):1123-32. PubMed ID: 9529328
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity.
Dickinson BL; Clements JD
Infect Immun; 1995 May; 63(5):1617-23. PubMed ID: 7729864
[TBL] [Abstract][Full Text] [Related]
3. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
[TBL] [Abstract][Full Text] [Related]
4. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.
Douce G; Fontana M; Pizza M; Rappuoli R; Dougan G
Infect Immun; 1997 Jul; 65(7):2821-8. PubMed ID: 9199455
[TBL] [Abstract][Full Text] [Related]
6. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.
de Haan L; Verweij WR; Feil IK; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
Immunology; 1998 Jul; 94(3):424-30. PubMed ID: 9767427
[TBL] [Abstract][Full Text] [Related]
7. The LTR72 mutant of heat-labile enterotoxin of Escherichia coli enhances the ability of peptide antigens to elicit CD4(+) T cells and secrete gamma interferon after coapplication onto bare skin.
Beignon AS; Briand JP; Rappuoli R; Muller S; Partidos CD
Infect Immun; 2002 Jun; 70(6):3012-9. PubMed ID: 12010992
[TBL] [Abstract][Full Text] [Related]
8. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity.
Ryan EJ; McNeela E; Pizza M; Rappuoli R; O'Neill L; Mills KH
J Immunol; 2000 Nov; 165(10):5750-9. PubMed ID: 11067933
[TBL] [Abstract][Full Text] [Related]
9. Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines.
Peppoloni S; Ruggiero P; Contorni M; Morandi M; Pizza M; Rappuoli R; Podda A; Del Giudice G
Expert Rev Vaccines; 2003 Apr; 2(2):285-93. PubMed ID: 12899578
[TBL] [Abstract][Full Text] [Related]
10. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.
Douce G; Turcotte C; Cropley I; Roberts M; Pizza M; Domenghini M; Rappuoli R; Dougan G
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1644-8. PubMed ID: 7878032
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine.
Hagiwar Y; Tsuji T; Iwasaki T; Kadowaki S; Asanuma H; Chen Z; Komase K; Suzuki Y; Aizawa C; Kurata T; Tamura S
Vaccine; 2001 Feb; 19(15-16):2071-9. PubMed ID: 11228379
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.
Bonenfant C; Dimier-Poisson I; Velge-Roussel F; Buzoni-Gatel D; Del Giudice G; Rappuoli R; Bout D
Infect Immun; 2001 Mar; 69(3):1605-12. PubMed ID: 11179334
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
[TBL] [Abstract][Full Text] [Related]
14. Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55.
Neidleman JA; Vajdy M; Ugozzoli M; Ott G; O'Hagan D
Immunology; 2000 Sep; 101(1):154-60. PubMed ID: 11012767
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.
De Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Immunology; 1999 Aug; 97(4):706-13. PubMed ID: 10457227
[TBL] [Abstract][Full Text] [Related]
16. Development of two novel nontoxic mutants of Escherichia coli heat-labile enterotoxin.
Park EJ; Chang JH; Kim JS; Chung SI; Yum JS
Exp Mol Med; 1999 Jun; 31(2):101-7. PubMed ID: 10410310
[TBL] [Abstract][Full Text] [Related]
17. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants.
Simmons CP; Mastroeni P; Fowler R; Ghaem-maghami M; Lycke N; Pizza M; Rappuoli R; Dougan G
J Immunol; 1999 Dec; 163(12):6502-10. PubMed ID: 10586042
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses.
Tierney R; Beignon AS; Rappuoli R; Muller S; Sesardic D; Partidos CD
J Infect Dis; 2003 Sep; 188(5):753-8. PubMed ID: 12934192
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin.
de Haan L; Feil IK; Verweij WR; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
Eur J Immunol; 1998 Apr; 28(4):1243-50. PubMed ID: 9565364
[TBL] [Abstract][Full Text] [Related]
20. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
